Most population health management strategies include initiatives to improve clinical outcomes and decrease the cost of care. Read this one-page interview with Dr. Tina Moen, Deputy Chief Health Officer at IBM Watson Health, as she shares the benefits and insights of collaborative medication management, including incorporating pharmacists in population health strategies.
In a panel discussion at the 12th annual SAS Health Analytics
Executive Forum in May 2015, leaders from Dignity Health,
Horizon Blue Cross Blue Shield of New Jersey, Janssen
Pharmaceuticals and SAS shared what they have done to prove
the value of analytics to their business leaders – and what has
worked for them as they developed an analytic culture in their
organizations and put analytic insights to work.
Cost reduction is a key criteria that executives often use when choosing initiatives to focus on. They are the ones that have the greatest potential to impact an organization's bottom line. Across life science organizations, a critical area for cost containment is training management.
This paper summarizes the results of a quantitative benchmarking survey to over 200 Life Science organizations. The study identifies the key compliance and performance improvement training topics they had addressed in 2011 along with key issues for 2012.
SOPs are critical to efficient manufacturing operations, quality control, and regulatory compliance. This paper reviews best practices for the Life Science industry for training on SOPs, and how learning management technology has the potential to improve learner retention through automated assessments.
Third party intermediaries have played starring roles in some of the most highly publicized global corruption trials. By any measure, third party intermediaries routinely rank high on the list of compliance worries for brand companies.
Good Manufacturing Practices (GMP) violations have become the new healthcare fraud as the Department of Justice (DOJ) tests out new legal theories under the False Claims Act (FCA). The Food and Drug Administration (FDA) has dusted off its regulatory authority to prosecute GMP violations.
Published By: Intermec
Published Date: Jun 20, 2013
This research, commissioned by Intermec and carried out by research company Vanson Bourne, surveyed 250 senior supply chain and distribution center managers at organizations with over 500 employees in the UK, France, Germany and North America. The interviews were conducted by telephone with respondents spanning industries including retail, manufacturing, distribution, transport, chemicals, logistics, pharmaceuticals, wholesale and FMCG. 50 interviews were conducted in each European country with 100 interviews taking place in North America during October 2012.
Download this white paper for a deeper look into the growing question surrounding the pharmaceutical industry--If customer centricity is so widely accepted as a way to unlock significant financial gains, why are companies so slow to adopt it?
But what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA for use of these networks. Adopting new technologies that allow employees to share information and exchange ideas with each other and with your customers is often the best way to achieve better business results, but doing so can involve considerable risk. That’s because the content people create using these technologies is subject to the scrutiny of regulators, legislators, and litigators. On top of that, increasing litigation has made it a business requirement to consider solutions that help bring down skyrocketing legal costs. Pharmaceuticals companies must be knowledgeable of, and abide by, specific information retention regulations in every country where they do business, including those countries that prohibit data from leaving the countries’ borders. Not having technology in place to help manage these requirements and increasing risks, or
Social Media Risks and Benefits for the Pharmaceuticals Industry
Drug makers are just beginning to realize how social networks can improve business processes. Social media helps your organization share information and exchange ideas with your customers quickly, but doing so can involve considerable risk. That’s because social media is subject to the scrutiny of regulators, legislators, and litigators. So, what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA. On top of that, increasing litigation has made it a business requirement to consider solutions that help bring down skyrocketing legal costs. Not having technology in place to help manage these requirements and increasing risks, or doing so without careful planning, can be a costly mistake.
Read this paper to gain an understanding of:
What the regulatory landscape of the pharmaceuticals industry looks like
What concerns you should be aware of f
St. Joseph’s Hospital Health Center has a total of 310 refrigerators throughout the organization. These items require strict temperature ranges for quality patient care and safety. Regulatory agencies perform audits requiring logs of temperature monitoring and corrective actions.
Read this case study to learn about how St. Joseph's deployed the wireless AeroScout Environmental Monitoring solution to leverage its wireless network by working with STANLEY Healthcare.
Published By: BlackLine
Published Date: Aug 06, 2018
The biotechnology and pharmaceutical industry is among the most heavily regulated industries in the world, challenged by evolving regulations, complex compliance requirements and close regulatory scrutiny. At the same time, companies must address the market pressures of globalization, the use of predictive data analytics and digital technologies, and the industry’s ongoing consolidation. In this challenging environment, confidence in internal controls is crucial.
Arm yourself against the powerful cyberweapons and
methods cyberattackers are using to compromise electrical
grids, manufacturing, oil and gas, pharmaceuticals, and
other critical infrastructure industries.
Published By: Motorola
Published Date: Feb 06, 2008
To stay competitive in the specialty pharmaceutical business, it is critical that a company's sales force, marketing team and executives have the business tools they need to keep them one step ahead of their rivals. Read this case study to learn how Good™ Mobile Messaging has helped the employees of MedPointe Pharmaceuticals stay connected to crucial information while they're on the road.
Published By: Intralinks
Published Date: Oct 03, 2013
For many companies, in particular in industries like pharmaceuticals, software development, or entertainment, their intellectual property is more valuable than any physical asset. And with the increasing need to collaborate with external business partners to accelerate product life cycles and enhance innovation, there is a greater risk for sensitive information to be compromised.
In this 6-page white paper, discover the benefits of how the right inter-enterprise collaboration tool can ensure secure document sharing and team collaboration, and what to keep in mind as you look for a provider.
Founded in 1929, the Rutgers Business School offers undergraduate and graduate degrees with programs in accounting, business administration, finance, information technology, pharmaceuticals and supply chain management. By leveraging cloud services, the burgeoning school can deliver rapid virtualization and easy single sign-on without cutting corners. Read this case study to learn more.
Published By: Cymfony
Published Date: Sep 13, 2007
The pharmaceutical industry is very interested in using social media to promote products, services and issues important to it. However, many drug firm executives are uncertain about how to tackle the legal and regulatory issues associated with social media communications.
This paper outlines some of the important considerations for encrypting data on tape, and is intended to help IT administrators make the right decision for their environment and their company's data security needs.
Published By: BlackBerry
Published Date: Dec 22, 2009
The Johnson & Johnson Family of Companies is comprised of the world's premier consumer health company, the world's largest medical devices and diagnostics company, the world's fourth-largest biologics company, and the world's seventh-largest pharmaceuticals company. With over 250 operating companies in 57 countries, Johnson & Johnson's Credo is to put the needs and well-being of the people they serve first.